Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.
Zarębska-Michaluk D, Jaroszewicz J, Buczyńska I, Simon K, Lorenc B, Tudrujek-Zdunek M, Tomasiewicz K, Sitko M, Garlicki A, Janczewska E, Dybowska D, Halota W, Pawłowska M, Pabjan P, Mazur W, Czauż-Andrzejuk A, Berak H, Horban A, Socha Ł, Klapaczyński J, Piekarska A, Blaszkowska M, Belica-Wdowik T, Dobracka B, Tronina O, Deroń Z, Białkowska-Warzecha J, Laurans Ł, Flisiak R. Zarębska-Michaluk D, et al. Among authors: pabjan p. J Gastroenterol Hepatol. 2020 Jul;35(7):1238-1246. doi: 10.1111/jgh.14936. Epub 2020 Jan 16. J Gastroenterol Hepatol. 2020. PMID: 31734959
[Peginterferon alpha-2b in patients with chronic hepatitis C].
Juszczyk J, Białkowska J, Bolewska B, Boroń-Kaczmarska A, Gładysz A, Halota W, Inglot M, Janas-Skulina U, Jabłkowski M, Jabłonska J, Jurczyk K, Kryczka W, Kuydowicz J, Lakomy EA, Lyczak A, Mach T, Michalska Z, Moczko J, Modrzewska R, Nazzal K, Pabjan P, Pawłowska M, Piszko P, Sikorska K, Swiqtek K, Tomasiewicz K, Topczewska-Staubach E, Wawrzynowicz-Syczewska M, Zarqbska-Michaluk D, Zejc-Bajsarowicz M. Juszczyk J, et al. Among authors: pabjan p. Pol Merkur Lekarski. 2004 Apr;16(94):353-7. Pol Merkur Lekarski. 2004. PMID: 15517932 Clinical Trial. Polish.
[Pegylated interferon-alfa 2a with ribavirin in chronic viral hepatitis C (final report)].
Juszczyk J, Baka-Cwierz B, Beniowski M, Berak H, Bolewska B, Boroń-Kaczmarska A, Cianciara J, Cieśla A, Dziambor A, Gasiorowski J, Gietka A, Gliwińska E, Gładysz A, Gonciarz Z, Halota W, Horban A, Inglot M, Janas-Skulina U, Janczewska-Kazek E, Jaskowska J, Jurczyk K, Knysz B, Kryczka W, Kuydowicz J, Lakomy EA, Logiewa-Bazger B, Lyczak A, Mach T, Mazur W, Michalska Z, Modrzewska R, Nazzal K, Pabjan P, Piekarska A, Piszko P, Sikorska K, Szamotulska K, Sliwińska M, Swietek K, Tomasiewicz K, Topczewska-Staubach E, Trocha H, Wasilewski M, Wawrzynowicz-Syczewska M, Wrodycki W, Zarebska-Michaluk D, Zejc-Bajsarowicz M. Juszczyk J, et al. Among authors: pabjan p. Przegl Epidemiol. 2005;59(3):651-60. Przegl Epidemiol. 2005. PMID: 16433307 Clinical Trial. Polish.
Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy.
Zarębska-Michaluk D, Buczyńska I, Simon K, Tudrujek-Zdunek M, Janczewska E, Dybowska D, Sitko M, Dobracka B, Jaroszewicz J, Pabjan P, Klapaczyński J, Laurans Ł, Mazur W, Socha Ł, Tronina O, Parczewski M, Flisiak R. Zarębska-Michaluk D, et al. Among authors: pabjan p. Can J Gastroenterol Hepatol. 2019 Mar 3;2019:4029541. doi: 10.1155/2019/4029541. eCollection 2019. Can J Gastroenterol Hepatol. 2019. PMID: 30941326 Free PMC article.
Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 study.
Piekarska A, Jabłonowska E, Garlicki A, Sitko M, Mazur W, Jaroszewicz J, Czauz-Andrzejuk A, Buczyńska I, Simon K, Lorenc B, Dybowska D, Halota W, Pawłowska M, Dobracka B, Berak H, Horban A, Tudrujek-Zdunek M, Tomasiewicz K, Janczewska E, Socha Ł, Laurans Ł, Parczewski M, Zarębska-Michaluk D, Pabjan P, Belica-Wdowik T, Baka-Ćwierz B, Deroń Z, Krygier R, Klapaczyński J, Citko J, Berkan-Kawińska A, Flisiak R. Piekarska A, et al. Among authors: pabjan p. AIDS Care. 2020 Jun;32(6):762-769. doi: 10.1080/09540121.2019.1645808. Epub 2019 Jul 25. AIDS Care. 2020. PMID: 31345052
Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis.
Zarębska-Michaluk D, Piekarska A, Jaroszewicz J, Klapaczyński J, Mazur W, Krygier R, Belica-Wdowik T, Baka-Ćwierz B, Janczewska E, Pabjan P, Dobracka B, Lorenc B, Tudrujek-Zdunek M, Tomasiewicz K, Sitko M, Garlicki A, Czauż-Andrzejuk A, Citko J, Dybowska D, Halota W, Pawłowska M, Laurans Ł, Deroń Z, Buczyńska I, Simon K, Białkowska J, Tronina O, Flisiak R. Zarębska-Michaluk D, et al. Among authors: pabjan p. Adv Med Sci. 2020 Mar;65(1):12-17. doi: 10.1016/j.advms.2019.09.002. Epub 2019 Dec 13. Adv Med Sci. 2020. PMID: 31841821 Free article.
Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection.
Flisiak R, Zarębska-Michaluk D, Jaroszewicz J, Lorenc B, Klapaczyński J, Tudrujek-Zdunek M, Sitko M, Mazur W, Janczewska E, Pabjan P, Dybowska D, Buczyńska I, Czauż-Andrzejuk A, Belica-Wdowik T, Berak H, Krygier R, Piasecki M, Dobracka B, Citko J, Piekarska A, Socha Ł, Deroń Z, Tronina O, Laurans Ł, Białkowska J, Tomasiewicz K, Halota W, Simon K, Pawłowska M. Flisiak R, et al. Among authors: pabjan p. Pol Arch Intern Med. 2020 Feb 27;130(2):163-172. doi: 10.20452/pamw.15181. Epub 2020 Feb 7. Pol Arch Intern Med. 2020. PMID: 32031541 Free article. No abstract available.
24 results